coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Regis Healthcare PCN, Arun · Health Inequalities Profile

    PCN U08235 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    31,650

    Registered population

    54.3% aged 18–64

    28.7%

    Aged 65+

    ICB 21.9% · England 17.9%

    4.6%

    Ethnic minority (non-White)

    1.8% Asian · England 9.6%

    5.6%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    ~1,646

    Core20 residents (est.)

    Resident basis; registered basis ~1,804 · see page 3

    6,429

    Hypertension register

    +5.16% in 3 yrs · England +5.60%

    341

    SMI register

    17.1% of Arun's

    762

    COPD register

    Reviews +4.42% in 3 yrs

    Forecast to 2030

    7,274

    Hypertension patients, 2030

    +845 on today

    72.0%

    QRISK ≥20% on statins, 2030

    +3.47pp over 3 yrs

    6.4%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    14.3%
    Deprivation and vaccination gaps at Bersted Green Surgery.

    Bersted Green Surgery holds all 1,804 estimated Core20 patients (14.3% share) and 33.0% QOF vaccination achievement, against 82.9% at Avisford Medical Group.

    -4.0%
    Asthma reviews and learning disability register lag England.

    Asthma reviews changed by -4.0% over 2023 to 2025 (England +4.4%), leaving about 730 patients unreviewed, while learning disability prevalence is 0.5% (Arun 0.8%).

    72.6%
    Hypertension blood pressure control exceeds comparator benchmarks.

    Blood pressure control is 72.6% under age 80 (England 67.8%, Arun 65.6%) and 82.3% at age 80+ (England 81.2%), though secondary statin therapy is.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65+ comprise 28.7% of the list, alongside 52 catchment care homes

    Regis Healthcare PCN serves 31,650 registered patients across three practices. Patients aged 65+ comprise 28.7% (9,092 patients), below Arun (29.2%) but above NHS Sussex Integrated Care Board (21.9%) and England (17.9%). Those aged 18–64 make up 54.3% (Arun 54.9%, ICB 60.5%, England 62.7%), and children aged 0–17 represent 16.9% (Arun 15.9%, ICB 17.7%, England 19.6%). Derived from Census usual residents rather than GP registers, 95.4% are White (Arun 95.8%, ICB 91.0%, England 81.1%), leaving a 4.6% non-White share. Projected list growth to 2030 is 1.8% (Arun 2.7%, ICB 2.1%, England 2.3%), using an unverified method.

    Age profile

    0–1716.9%
    18–6454.3%
    65+28.7%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White95.4%
    Asian1.8%
    Mixed1.6%
    Other0.7%
    Black0.5%

    Older people · falls rows are Arun local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Arun LA)2,3272,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)79.3%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)63.8%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Arun LA)1,2169819552024/25
    Falls deaths, all ages, per 100,000 (Arun LA)13.314.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 5.6% overall and concentrated entirely at Bersted Green Surgery

    Registered Core20 prevalence (patients living in the most deprived 20% of areas in England, IMD deciles 1 and 2) is 5.6%, below England (21.0%), Arun (9.8%) and NHS Sussex Integrated Care Board (9.2%). Weighted practice share is 5.7%, reflecting a 0.13 percentage point reconciliation difference. Core20 is concentrated entirely at Bersted Green Surgery (14.3%, an estimated 1,804 patients), with Arundel Surgery and Avisford Medical Group at 0.0%. A resident-based estimate finds 1,646 people. Targeted inequality resources should focus on Bersted Green Surgery rather than PCN-wide distribution.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Bersted Green14.3% · 1,804 patients
    Arundel0.0% · 0 patients
    Avisford Medical0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    341

    SMI register

    1.07% recorded prevalence

    167

    Learning disability register

    0.53% recorded prevalence

    52

    Care homes, 1,581 beds

    In the PCN catchment

    8.9%

    Provide unpaid care

    Arun, Census 2021

    Learning disability prevalence is 0.5% (167 patients; Arun 0.8%, ICB 0.6%, England 0.6%), and severe mental illness is 1.1% (341 patients; Arun 1.1%, ICB 1.1%, England 1.0%). Catchment care homes total 52 (1,581 beds). Arun context includes about 2,800 unpaid carers and 16 rough sleepers. Lower recorded learning disability prevalence against comparators does not establish under-detection or unmet need, but could warrant clinical record review.

    Severe mental illness: physical health checks

    Across 341 severe mental illness patients, BMI recording is 78.8% (England 82.1%) and alcohol recording is 78.5% (England 81.8%), while blood pressure checks reach 83.6% (England 83.4%). Lower recording may leave metabolic risks unmonitored.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,429

    Hypertension register

    +5.16%

    Register growth, 3 yrs

    Arun +4.55% · England +5.60%

    +5.37pp

    BP control, under 80

    ≤140/90 · +0.93pp aged 80+

    +845

    More patients by 2030

    Forecast 7,274 (22.41%)

    Hypertension case-finding and control

    Hypertension register prevalence is 20.3% (6,429 patients), above Arun (19.8%), NHS Sussex Integrated Care Board (16.3%) and England (15.2%). Blood pressure monitoring reached 92.3% (England 90.0%), and patients treated to target reached 74.4% (England 70.3%). Blood pressure control is 72.6% in patients aged under 80 (England 67.8%) and 82.3% in patients aged 80 and over (England 81.2%), though Arundel Surgery achieved 78.0% in the 80 and over cohort. Hypertension control exceeds England overall, but lower control in patients aged 80 and over at Arundel Surgery highlights an opportunity to prioritise older-adult recall.

    Lipids and statins

    QRISK ≥ 20% lipid therapy is 64.5% (England 63.6%). However, secondary prevention statin treatment in diabetes with CVD history is 80.6% (England 84.4%) and lipid therapy in CKD is 68.6% (England 70.3%). Secondary prevention lipid coverage trails England, indicating that high-risk diabetic and CKD patients require prioritised treatment review.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202670,360£3.00£2.42£1.86£211,080
    Cardiovascular (all), 202591,905£3.23£3.32£3.33£296,853

    In 2026, lipid-modifying drugs cost £3.00 per item across 70,360 items (Arun £2.81, NHS Sussex Integrated Care Board £2.42, England £1.86), spending £80,210 more than at England's unit cost. Unit cost is higher than England and ICB benchmarks, pointing to an opportunity to review lipid-modifying prescribing choices.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −4.04%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +3.08%

    Asthma prevalence, PCN 3-yr % change

    COPD annual reviews reach 85.6% (England 76.4%, Arun 74.5%) across 762 registered patients. Conversely, 12-month asthma reviews fell 4.0% over 2023 to 2025 (England +4.4%), with current PCN coverage at 67.2% across 2,222 patients, leaving about 730 unreviewed. At Bersted Green Surgery, asthma review coverage is 59.7%. Paediatric asthma prescribing stands at 1,966 items per 1,000 aged 5-19 (England 1,488 rate), while second-hand smoke recording is 76.5% (England 78.8%). Falling asthma reviews may leave exacerbation risks unmonitored despite high prescribing volumes.

    Cancer register and children's immunisation

    Cancer prevalence is 5.4% (1,710 patients; England 3.8%). In childhood immunisation, age-5 MMR1 is 92.6% (England 91.7%), while MMR2 is 80.9% (England 82.8%, NHS Sussex ICB 87.1%), showing an 11.7 pp dose difference (18.4 pp at Bersted Green Surgery). MMR1 at 24 months is 83.0% (England 88.3%). Lower second-dose uptake may leave children incompletely protected before school entry.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months91.5%

    England 91.0%

    6-in-1 complete primary course at 24 months93.6%

    England 92.2%

    MMR dose 1 at 24 months83.0%

    England 88.3%

    MMR dose 2 at age 580.9%

    England 82.8%

    4-in-1 pre-school booster at age 582.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    In 2022, across NHS Sussex ICB, 58.5% of cancers with a known stage (4,799 of 8,209) were diagnosed at stage 1 or 2, above England (55.3%) but 16.5 pp below the 75.0% national ambition by 2028 (about 1,360 extra cases needed). Known stage was recorded for 64.3% of registered cancers (8,209 of 12,766; England 67.0%). This reflects system performance, not PCN delivery. Locally, PCN cervical screening coverage is 69.2% (England 66.8%) but is 58.2% at Bersted Green Surgery, while breast screening coverage is 69.5% (England 69.9%). Primary care screening gaps at lower-uptake practices may delay early cancer detection across the wider system.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), University Hospitals Sussex NHS Foundation Trust met the 62-day referral to treatment standard in 65.2% of pathways, 19.8 pp below the 85.0% standard, trailing NHS Surrey and Sussex Integrated Care Board (71.5%), England (71.2%), Portsmouth Hospitals University NHS Trust (75.2%) and Royal Surrey NHS Foundation Trust (84.5%). The 28-day faster diagnosis rate was 74.0% (standard 75.0%, England 79.3%). For diagnostics, 12.9% waited 6+ weeks across all tests (England 23.1%), though colonoscopy waits reached 39.3% (England 30.8%). Acute pathway bottlenecks may extend treatment intervals for referred PCN patients.

    Pathways within standard (%)SussexPortsmouthRoyal SurreySurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)74.0166.8182.6279.2979.32
    31-day treatment (96%)76.7994.7896.4390.4592.50
    62-day referral to treatment (85%)65.2075.2084.4871.5171.16
    Diagnostic waits over 6 weeks (%)SussexPortsmouthRoyal SurreyEngland
    MRI5.6250.360.0021.40
    CT8.5713.060.159.92
    Echocardiography0.3932.751.5528.48
    Colonoscopy39.3582.520.0030.83
    Gastroscopy20.0274.880.0029.02
    All 15 DM01 tests12.9551.968.8223.14
    Community services activityWest Sussex residentsSurrey and Sussex ICB
    Care contacts78,050309,615
    Referrals16,01566,930
    Patients with a contact19,77085,660

    Community services (residents of West Sussex), Jun 2026 (provisional). In Jun 2026 (provisional), experimental community data recorded 78,050 care contacts across 19,770 West Sussex residents, with adults aged 65+ accounting for 72.7% of contacts. Across NHS Surrey and Sussex Integrated Care Board, 309,615 contacts were recorded across 85,660 patients. High community contact volume among older residents underscores demand for joined-up post-diagnosis care.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation is sharp across clinical vaccination achievement and patient-reported telephone access

    Across the 2025/26 Quality and Outcomes Framework, clinical domain achievement is consistently high across all three practices (99.8% to 100.0%). However, vaccination and immunisation achievement reveals a 49.9 pp range, from 33.0% at Bersted Green Surgery (22.1 pp below England's 55.2%) to 82.9% at Avisford Medical Group, while personalised care adjustment rates remain between 1.6% and 4.0%.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Arundel Surgery1140.077.3%75.1%89.1%
    Avisford Medical1220.041.5%79.5%73.8%
    Bersted Green9814.346.2%75.4%71.4%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNArunAssetPCNArun
    Care homes (catchment)52 (1,581 beds)n/aSchools (catchment)48n/a
    Children's centres47Places of worship4668
    Libraries27Homelessness support (VCS)0no data
    Day centres (VCS)n/a1Carers support groups (VCS)n/a1
    Primary schools (LA maintained)1721Primary academies919
    Special schoolsn/a1

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Asthma annual review recall and templates

    Asthma reviews in the last 12 months fell 4.0% over 2023 to 2025 (England +4.4%); at 67.2% coverage across 2,222 patients (59.7% at Bersted Green Surgery), about 730 lack a recorded review. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Learning disability register validation and audit

    Recorded learning disability prevalence is 0.5% (167 patients) against 0.6% in England and 0.8% in Arun (+1.9% change over 2023 to 2025 vs England +5.4%), a modelled gap of +19 to +76 patients. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Option 3

    Complete physical checks on SMI register

    Across 341 SMI patients (1.1% prevalence), 12-month BMI recording is 78.8% (England 82.1%) and alcohol recording is 78.5% (England 81.8%, +1.3 pp change over 2023 to 2025 vs England +5.4 pp). Low cost, quick to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Targeted Core20 outreach and reconciliation (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI metabolic check recall (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Older adult blood pressure review (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool MMR second dose recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice telephone triage review (p9)GPPS last request led to a booked appointment · GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Asthma annual review recall and templates (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN & Practice
    Option 2 · Learning disability register validation and audit (p12)Learning disability register · Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Option 3 · Complete physical checks on SMI register (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15